Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidance In The Works For Unmet Need In Serious Bacterial Infections

Executive Summary

CHICAGO – FDA hopes to have a draft guidance for industry on developing antibiotics for serious bacterial infection with unmet medical need ready for public review in the first quarter of 2012, Edward Cox, director of FDA’s Office of Antimicrobial Products, told an audience at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago.
Advertisement

Related Content

FDA Emphasizes Pathogen ID In Complicated Intra-Abdominal Infection Guidance
FDA Continues To Clarify Antibiotic Requirements With New Guidance On Complicated UTI
Panel Gives Mixed Reviews To Using Single Trial For Community-Acquired Pneumonia
Rare Diseases Need Ongoing Natural History Studies To Speed Trials, FDA Says
Sponsors Seek One-Trial Approval Of Antibiotics For Drug-Resistant Bugs
Pneumonia Guidances Revisited: FDA Cmte. To Weigh Study Design Issues Again
Sponsors Seek One-Trial Approval Of Antibiotics For Drug-Resistant Bugs
Pneumonia Guidances Revisited: FDA Cmte. To Weigh Study Design Issues Again
PhRMA Urges FDA To Set Non-Inferiority Margin For Skin Infection Drugs
FDA Raises Breakpoints In Final Labeling For Forest's Ceftaroline

Topics

Advertisement
UsernamePublicRestriction

Register

PS053802

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel